254 related articles for article (PubMed ID: 33671187)
1. Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides.
Lee SY
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33671187
[TBL] [Abstract][Full Text] [Related]
2. A Focused Review on Molecular Signalling Mechanisms of Ginsenosides Anti-Lung Cancer and Anti-inflammatory Activities.
Jung DH; Nahar J; Mathiyalagan R; Rupa EJ; Ramadhania ZM; Han Y; Yang DC; Kang SC
Anticancer Agents Med Chem; 2023; 23(1):3-14. PubMed ID: 35319393
[TBL] [Abstract][Full Text] [Related]
3. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
4. Antimelanogenesis Activity of Hydrolyzed Ginseng Extract (GINST) via Inhibition of JNK Mitogen-activated Protein Kinase in B16F10 Cells.
Han JS; Sung JH; Lee SK
J Food Sci; 2016 Aug; 81(8):H2085-92. PubMed ID: 27356239
[TBL] [Abstract][Full Text] [Related]
5. The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition.
Arafa EA; Refaey MS; Abd El-Ghafar OAM; Hassanein EHM; Sayed AM
Heliyon; 2021 Nov; 7(11):e08354. PubMed ID: 34825082
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy.
Murai M; Yamamura K; Hashimoto-Hachiya A; Tsuji G; Furue M; Mitoma C
J Dermatol Sci; 2018 Jul; 91(1):97-103. PubMed ID: 29703420
[TBL] [Abstract][Full Text] [Related]
7. Compound K inhibits MMP-1 expression through suppression of c-Src-dependent ERK activation in TNF-α-stimulated dermal fibroblast.
Lee CS; Bae IH; Han J; Choi GY; Hwang KH; Kim DH; Yeom MH; Park YH; Park M
Exp Dermatol; 2014 Nov; 23(11):819-24. PubMed ID: 25181017
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice.
Su GY; Li ZY; Wang R; Lu YZ; Nan JX; Wu YL; Zhao YQ
Food Funct; 2019 Jul; 10(7):3992-4000. PubMed ID: 31206110
[TBL] [Abstract][Full Text] [Related]
9. Tension Force Downregulates Matrix Metalloproteinase Expression and Upregulates the Expression of Their Inhibitors through MAPK Signaling Pathways in MC3T3-E1 cells.
Karasawa Y; Tanaka H; Nakai K; Tanabe N; Kawato T; Maeno M; Shimizu N
Int J Med Sci; 2015; 12(11):905-13. PubMed ID: 26640410
[TBL] [Abstract][Full Text] [Related]
10. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
[TBL] [Abstract][Full Text] [Related]
11. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.
Liacini A; Sylvester J; Li WQ; Zafarullah M
Matrix Biol; 2002 Apr; 21(3):251-62. PubMed ID: 12009331
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
15. Ginsenosides from Korean red ginseng inhibit matrix metalloproteinase-13 expression in articular chondrocytes and prevent cartilage degradation.
Lee JH; Lim H; Shehzad O; Kim YS; Kim HP
Eur J Pharmacol; 2014 Feb; 724():145-51. PubMed ID: 24384406
[TBL] [Abstract][Full Text] [Related]
16. Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells.
Park HM; Kim SJ; Mun AR; Go HK; Kim GB; Kim SZ; Jang SI; Lee SJ; Kim JS; Kang HS
J Ethnopharmacol; 2012 Jun; 141(3):1071-6. PubMed ID: 22472111
[TBL] [Abstract][Full Text] [Related]
17. Ursonic acid exerts inhibitory effects on matrix metalloproteinases via ERK signaling pathway.
Son J; Lee SY
Chem Biol Interact; 2020 Jan; 315():108910. PubMed ID: 31790661
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of panduratin A on UV-induced activation of mitogen-activated protein kinases (MAPKs) in dermal fibroblast cells.
Shim JS; Kwon YY; Han YS; Hwang JK
Planta Med; 2008 Oct; 74(12):1446-50. PubMed ID: 18683126
[TBL] [Abstract][Full Text] [Related]
19. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
